Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Alan V. Boddy Johann de Bono Lillian Siu |
| Publication date | April 21, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |